Research graph
References from Unmasking Brugada Syndrome With Oral Propafenone in a Resource-Limited Setting: A Case Report. Local targets link to admitted publications; unresolved targets remain external evidence.
Brugada syndrome: more than a monogenic channelopathy
10.3390/biomedicines11082297 · 2023 · External reference
Brugada syndrome
10.1016/j.jacep.2021.12.001 · 2022 · External reference
Unresolved reference
External reference
Brugada-type ECG pattern and extreme QRS complex widening with propafenone overdose
10.1111/j.1540-8167.2006.00453.x · 2006 · External reference
National Basic Medicines List (CNMB): Therapeutic Register. (Book in Spanish)
2019 · External reference
Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association
10.1161/01.cir.0000152479.54298.51 · 2005 · External reference
Unresolved reference
External reference
Brugada syndrome: a comprehensive review of fundamental and electrophysiological new findings
10.3390/jcm12206590 · 2023 · External reference
2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: developed by the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC) endorsed by the Association for European Paediatric and Congenital Cardiology (AEPC)
10.1093/eurheartj/ehac262 · 2022 · External reference
Drugs and Brugada syndrome patients: review of the literature, recommendations, and an up-to-date website (www.brugadadrugs.org)
10.1016/j.hrthm.2009.07.002 · 2009 · External reference
Intermittent Brugada syndrome misdiagnosed as acute myocardial infarction and unmasked with propafenone
10.1136/heart.87.6.543 · 2002 · External reference
J-wave syndromes expert consensus conference report: emerging concepts and gaps in knowledge
10.1093/europace/euw235 · 2017 · External reference
High risk electrocardiographic markers in Brugada syndrome
10.1016/j.ijcha.2018.03.001 · 2018 · External reference
Drugs and Brugada syndrome patients: review of the literature, recommendations, and an up-to-date website (www.brugadadrugs.org)
10.1016/j.hrthm.2009.07.002 · ExternalCitation · doi-reference
High risk electrocardiographic markers in Brugada syndrome
10.1016/j.ijcha.2018.03.001 · ExternalCitation · doi-reference
Brugada syndrome
10.1016/j.jacep.2021.12.001 · ExternalCitation · doi-reference
2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: developed by the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC) endorsed by the Association for European Paediatric and Congenital Cardiology (AEPC)
10.1093/eurheartj/ehac262 · ExternalCitation · doi-reference
J-wave syndromes expert consensus conference report: emerging concepts and gaps in knowledge
10.1093/europace/euw235 · ExternalCitation · doi-reference
Brugada-type ECG pattern and extreme QRS complex widening with propafenone overdose
10.1111/j.1540-8167.2006.00453.x · ExternalCitation · doi-reference
Intermittent Brugada syndrome misdiagnosed as acute myocardial infarction and unmasked with propafenone
10.1136/heart.87.6.543 · ExternalCitation · doi-reference
Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association
10.1161/01.cir.0000152479.54298.51 · ExternalCitation · doi-reference
Brugada syndrome: more than a monogenic channelopathy
10.3390/biomedicines11082297 · ExternalCitation · doi-reference
Brugada syndrome: a comprehensive review of fundamental and electrophysiological new findings
10.3390/jcm12206590 · ExternalCitation · doi-reference
